• September 30. 2025 - EPH_Provider Referral Memo_DME form
  • September 19. 2025 - EPH-PR-REMINDER BEHAVIORAL HEALTH Improving Discharge Planning Coordination
  • September 19. 2025 - EP-PR-Provider Guidance_Nutritional Supplements for DME Providers
  • September 19. 2025 - EPH- Reminder_CLIA Updates for Some Procedure Codes
  • September 19. 2025 - 11900-39-EPH-Provider Revalidation Flyer-V2
  • September 19. 2025 - EPH-PR-PEMS Prior Authorizations Extended Due to 2025 Flooding
  • July 16. 2025 - Updated Rider 32 Provider Notification
  • July 16. 2025 - El Paso Health Sports Physical Flyer
  • July 14. 2025 - Physical, Occupational, and Speech Therapy Provider Training Invitation
  • July 14. 2025 - Frew Litigation Hold Notice
  • July 14. 2025 - External Vendor Reminder Litigation Hold Attachment July '24/'25
  • June 11. 2025 - EPH-TPA Fax Blast - Template Genetic Testing
  • June 11. 2025 - HEPH-PR- Rvldtn Due Dts and Rtrctve Enrllmnt Prd Gp Clsrs Extndd to Nov. 30 2025
  • June 10. 2025 - Home HealthDME Provider Orientation Flyer
  • June 9. 2025 - Rental of Dual-Function Home Ventilators a Benefit of Texas Medicaid Effective April 1 2025
  • May 22. 2025 - HHAeXchange System Survey Now Available
  • May 22. 2025 - STAR+PLUS Members Extension of Continuity of Care Period to August 31, 2025
  • May 16. 2025 - Updated PEMs Credentialing Postponed
  • May 9. 2025 - Prior Authorization Criteria for Tecelra- Effective April 1, 2025
  • May 9. 2025 - Coming Soon- PEMS to Be Updated to Allow Provider Credentialing
  • May 9. 2025 - Change in PDL Status for the Immunomodulators, Atopic Dermatitis and Ophthalmics, Anti-Inflammatories Drug Classes - Effective April 4, 2025
  • May 5. 2025 - EFT Communication Flyer
  • May 2. 2025 - Provider Advisory Group Digital Flyer
  • April 30. 2025 - April Reminder - Timely Documentation
  • April 14.2025 - EPH- Behavioral Health Provider Specialty Training Invite
  • April 7.2025 - Electronic Funds Transfer (EFT) Fraud Scheme
  • April 4.2025 - Vaccine Recommendations in the Context of Local Outbreak
  • April 4.2025 - List of 2024 Cost Reports Required for LTSS Providers
  • April 1.2025 - EPH-Reminder: March 2025 Specialty Drug List Now Available
  • March 25.2025 - DSHS Grand Rounds Flyer
  • March 21.2025 - RSV Season and Synagis Prior Authorization Ends April 14 2025 for El Paso Region
  • March 20.2025 - COVID Test Kit and Vaccine Coverage in the Pharmacy Benefit Memorandum
  • March 18.2025 - Care For Older Adults Flyer
  • March 17.2025 - Rescheduled Training for PCP, OB, Family, Internist and Geriatric Providers
  • March 7.2025 - Medicaid Provider Enrollment Revalidation Flexibilities and Claims Reprocessing
  • March 7.2025 - Prior Authorization Criteria for Sickle Cell Disease Therapy
  • March 7.2025 - Reminder: January 2025 JW Modifier Eligible Drug List Available
  • Feb 25.2025 - EPH Provider Referral Memo DME Form
  • Feb 25.2025 - STAR+PLUS Members Transition Continuity of Care Extension of Transition Period to May 31 2025
  • Feb 21.2025 - EPH Provider Satisfaction Survey Flyer
  • Feb 18.2025 - EPHSP LTSS Provider Training Invitation
  • Feb 18.2025 - The Certified Family Partner (CFP) Services New Medicaid Benefit Effective March 1 2025
  • Feb 14.2025 - EVV VMUR Updates
  • Feb 6.2025 - VDP to Bgn Mlng Undr-Trtmnt of Chrnc Hptts C Vrs Infctns Rtrspctve DUR Ut
  • Feb 5.2025 - Register for HHAeXchange EVV System Training for CDS Employers
  • Feb 4.2025 - CoCM Services Provided by FQHCs and RHCs - Effective March 1 2025
  • Feb 4.2025 - Appointment Availability Standards
  • Jan 27.2025 EP-PR-Reminder Revalidation Due Date Extension and Retroactive Enrollment Period Effective Dates
  • Jan 27.2025 -EPH- Provider Advisory Group Flyer
  • Jan 16.2025 - EPH-PR-Prior Authorization Criteria for Kisunla Effective Feb. 1 2025
  • Jan 13.2025 - EPH-PR-2024 Cost Report Training Information for LTSS Providers
  • Jan 7.2025 - Urgent Changes to COVID for the Pharmacy Benefit
  • Jan 6.2025 - Coverage of Zurzuvae on the Texas Medicaid Formulary
  • Dec 20.2024 - Claims Check run schedule for Christmas Week
  • Dec 6.2024 - In Lieu of Services
  • Dec 5.2024 - Revalidation Due Date Extension and Retroactive Enrollment Period Effective Dates
  • Dec 3.2024 - TMPPM Language Update for Certain HTW Telehealth Services Effective Dec. 1 2024
  • Dec 3.2024 - Wegovy Coverage and Implementation of Clinical Prior Authorization for Medicaid
  • Nov 20.2024 - EPH PR- Electronic Visit Verification (EVV) Alternative Device Reduction Schedule.pdf
  • Nov 19.2024 - Claims Check run schedule for Thanksgiving Week
  • Nov 13.2024 - Prior Authorization Criteria for Anktiva Effective Nov. 1 2024
  • Nov 1.2024 - 2024-2025 Synagis Flyer
  • Oct 15.2024 - EVV Policy Handbook Revisions Effective September 12 2024
  • Oct 15.2024 - In Lieu of Services.pdf
  • Oct 9.2024 - EPH PR-Chng in Prfrrd Drg Lst Stts for Gnrc Sldnfl Orl Sspnsn Tks ffct Sept. 25
  • Oct 9.2024 - EPH Notice_HHSC to Remove Oxbryta Products from all Formularies as of Oct. 10, 2024
  • Oct 09.2024 - Notice_EVV Compliance Grace Period Ends Dec. 31
  • Oct 09.2024 - RSV Vaccine Procedure Code 90683 to Become a Benefit of Texas Medicaid Effective October 1 2024.pdf
  • Oct 08.2024 - Enfamil Gentlease Enfamil A.R and Enfamil Reguline Possible Shortages.pdf
  • Oct 04.2024 - Subscripe to EPH Providers E-News Update
  • Oct 04.2024-VEPH Memo_Some COVID-19 Vaccine Procedure Codes No Longer a Benefit of Texas Medicaid & CHIP Effective Oct. 1
  • Sept 26.2024-VDP Changed PDL Status for Blucocorticoids Inhaled Drug Class Effective Dec. 15 2023
  • Sept 20.2024.Notice_HHSC to Begin Surveying AFC Home Providers for SFY 2023
  • Sept 20.2024.Change in Preferred Drug List Status for Glucocorticoids Inhaled Drug Class Takes Effect August 22
  • Sept 05.2024.El Paso Health STAR+PLUS Continuity of Care Transition Process for EPH Members
  • Aug 18.2024.COVID-19 Vaccine and Vaccine Administration Medicaid and CHIP Updates Effective October 1 2024
  • Aug 18.2024.Sports Physical for STAR and CHIP members
  • Aug 13.2024.Genetic Services Biomarker Testing Benefits for Texas Medicaid Effective September 1 2024
  • Aug 8.2024.CHIP MCOs Reinstatement of CHIP Co-pays for COVID-19 services
  • Aug 8.2024.Home Telemonitoring Services Adding Federally Qualified Health Centers and Rural Health Clinics as Providers, updated
  • Aug 8.2024.UPDATE - Enfamil Gentlease Enfamil A.R and Enfamil Reguline possible shortages
  • Aug 2.2024.Psychosocial Care Provider Flyer
  • Jul 19.2024.Fiscal Year 2025 Enhancement for Attendant Compensation- Request for Participation
  • Jul 17.2024.Enfamil Reguline 12.4oz Powder Limited Availability in Retail Stores Until Mid-July 2024
  • Jul 15.2024.Update to Smallpox and Mpox Vaccine Reimbursement for Texas Medicaid
  • Jun 25.2024.EP-PR-Reminder about EVV Home Phone Landline Requirements.pdf
  • Jun 17.2024.Waive Timely Filing of Electronic Visit Verification (EVV) Service Claims Impacted by the VMUR Hold 6.14.24
  • Jun 17.2024.Drugs Added to Medicaid CHIP Formularies on June 6 2024
  • Jun 06.2024.Calendar Year 2024 EVV Proprietary System Request Form Submission Deadline July 15 2024
  • May 31.2024.Information for Medicaid Providers - Upcoming Changes to STAR+PLUS
  • May 30.2024.Hepatitis C Prescriber Letter - Texas Medicaid HepCure
  • May 30.2024.EVV Compliance Grace Period Extended for Personal Care Services to Dec. 31 2024
  • May 30.2024.National Drug Codes Added to Medicaid CHIP Formularies on May 8 and May 10 2024
  • May 16.2024.Change in Preferred Drug List Status for Lincosamides-Oxazolidinones-Streptogramins Drug Class Effective May 6 2024
  • May 16.2024.Waive Timely Filing of Electronic Visit Verification (EVV) Service Claims Impacted by the VMUR Hold
  • May 16.2024.Program and Service Requirements Schedules Available in EVV System.pdf
  • Apr 26.2024.EVV Alternative Device Phase-Out Schedule for Public Comment- Due by May 15
  • Apr 26.2024.Updates to the EVV Visit Maintenance Processes Hold for Dates of Service Prior to Go-Live Date
  • Apr 25.2024.Chikungunya Virus Vaccine Is Now a Benefit of Texas Medicaid
  • Apr 25.2024.Vaccine Services Procedure Code 90623 is Now Available Through TVFC Effective April 1 2024
  • Apr 25.2024.Prior Authorization Criteria for Adzynma (Apadamtase alfa) and Pombiliti (Cipaglucosidase alfa-atga)
  • Apr 16.2024.Reminder_LPC and LMFT Providers Must Enroll in Medicare Effective March 1, 2024
  • Apr 16.2024.Newly Required PDMP Data Information for CMS Annual Drug Utilization Review Survey for Federal Fiscal Year 2024
  • Apr 12.2024.EVV Home Health Care Services (HHCS) Service Bill Codes Table Now Available
  • Mar 29.2024.Cyberattack-Change Healthcare Incident Impact and Options
  • Mar 29.2024.New EVV Visit Transaction Rejection Codes to Begin April 1
  • Mar 22.2024.Change in PDL Status for Antivirals Oral Drug Class Effective March 7
  • Mar 22.2024.2023-24 RSV Season and Synagis Prior Authorization Ended March 15 For All Regions
  • Mar 22.2024.Updates to HHAeXchange Training Resources for EVV Program Providers and FMSAs
  • Mar 22.2024.EVV Claims Matching Resumes April 1 2024; Unmatched EVV Claims will Deny for Payment
  • Mar 14.2024.Omnipod 5 Added to Medicaid CHIP Drug Formularies On Feb. 22
  • Mar 12.2024.Change in Preferred Drug List Status for Immunosuppressives Oral Drug Class Takes Effect Feb.12
  • Feb 15.2024.Updates to Vaccine Administration Procedure Code M0201
  • Feb 9.2024.EVV Claims Matching Bypass from Jan 1 to March 31
  • Feb 6.2024.Hepatitis C Educational Webinar For Prescribers Occurs March 6 2024
  • Feb 6.2024.Reminder HEDIS SEASON
  • Jan 25.2024.RSV Monoclonal Antibody Nirsevimab is a Benefit of Texas Medicaid and CHIP
  • Jan 25.2024.Provider Type and Places of Service Update for Procedure Code 96372
  • Jan 16.2024.Pfizer Oral COVID-19 Drug Paxlovid Added to Formulary.pdf
  • Jan 05.2024.EPH-PR-UPDATE OB_GYN Prior Authorization No Longer Required for certain Genetic Testing
  • Jan 02.2024.Diabetic Equipment and Supplies-Home Health Policy Update Effective Feb. 1 2024
  • Dec 20.2023.RSV Vaccine Procedure Code 90678 is Now a Benefit for Pregnant Individuals Effective October 1 2023
  • Dec 14.2023.EVV Program Providers and FMSAs Must Download Visit Data by Dec.22
  • Dec 14.2023.Change in Preferred Drug List Status for Glucocorticoids Inhaled Drug Class Takes Effect Dec. 15
  • Dec 14.2023.Coverage of Vyjuvek Begins Jan. 2024; Prior Authorization Effective Feb. 2024.pdf
  • Dec 14.2023.Coverage of Adstiladrin Begins Jan. 2024; Prior Authorization Effective Feb. 2024
  • Dec 12.2023.Coverage of Roctavian Begins Jan 2024; Prior Authorization Effective Feb 2024
  • Dec 11.2023.Complete EVV Visit Maintenance and Submit VMURs Before Losing Access
  • Dec 08.2023.Memo CLIA Guidance
  • Nov 30.2023.EVV Cures Act Home Health Care Services (HHCS) Onboard Now.pdf
  • Nov 29.2023.HHAeXchange Electronic Visit Verification (EVV) Training Resources
  • Nov 28.2023.Change in Preferred Drug List Status for the Macrolides-Ketolides
  • Nov 17.2023.Thanksgiving Holiday Office Closure and Check Run Schedule
  • Nov 15.2023.Telemedicine and Telehealth Benefit Updates for Rural Health Clinics
  • Sept 25.2023.2023-2024 Synagis Season
  • Sept 22.2023.EVV Onboard with HHAeXchange
  • Sept 22.2023.Qualifications and Ordering an EVV Alternative Device Policy